Everts · International journal of molecular sciences 2024 · narrative review · n=?

Profound Properties of Protein-Rich, Platelet-Rich Plasma Matrices as Novel, Multi-Purpose Biological Platforms in Tissue Repair, Regeneration, and Wound Healing.

Cited 62 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Narrative review of biological mechanisms without original clinical or experimental data

PubMed 39063156 · doi:10.3390/ijms25147914 · record verified 2026-08-26

What was done

This narrative review synthesizes the biological characteristics and preparation methods of autologous platelet-rich plasma (PRP), platelet-poor plasma (PPP), and combined protein-rich, platelet-rich plasma (PR-PRP) matrices. It details the rationale for processing PPP via ultrafiltration to concentrate functional plasma proteins (such as fibrinogen, albumin, and alpha-2-macroglobulin) and growth factors (such as IGF-1 and HGF) rather than discarding it, alongside platelet concentrates for wound healing and regenerative medicine applications.

What was found

The abstract reports no quantitative measurements or comparative outcome statistics. Conceptually, it describes that PPP contains growth factors residing outside platelet alpha-granules (specifically IGF-1 and HGF) along with exosomes. Ultrafiltration removes excess water and smaller molecules while preserving functional plasma proteins; combining this concentrate with PRP yields a PR-PRP matrix that facilitates interactions with resident cells (macrophages, fibroblasts, mesenchymal stem cells) and provides sustained release of signaling molecules during fibrinolysis.

Why it matters

Standard PRP protocols typically discard the PPP fraction. This work highlights how ultrafiltered PPP can be combined with PRP to create a denser protein scaffold with supplemental growth factors, establishing a mechanistic framework for developing multi-purpose biological platforms in wound care and tissue repair.

Limits

The abstract is strictly descriptive and mechanistic, presenting no primary empirical data, clinical trial outcomes, or direct comparative metrics against standard PRP or controls. In vivo efficacy, long-term durability, clinical safety, optimal ultrafiltration parameters, and standardization across patient populations are not reported.

Cited by